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ABSTRACT 
This molecular study is the first report, to the best of our knowledge, on identification of 
norovirus, NoV GII.4 Sydney 2012 variants, from blue mussels collected from UK coastal 
waters. Blue mussels (three pooled samples from twelve mussels) collected during the 2013 
summer months from UK coastal sites were screened by RT-PCR assays. PCR products of 
RdRP gene for noroviruses were purified, sequenced and subjected to phylogenetic analysis. 
All the samples tested positive for NoVs. Sequencing revealed that the NoV partial RdRP 
gene sequences from two pooled samples clustered with the pandemic “GII.4 Sydney 
variants” whilst the other pooled sample clustered with the NoV GII.2 variants. This 
molecular study indicated mussel contamination with pathogenic NoVs even during mid-
summer in UK coastal waters which posed potential risk of NoV outbreaks irrespective of 
season. As the detection of Sydney 2012 NoV from our preliminary study of natural coastal 
mussels interestingly corroborated with NoV outbreaks in nearby areas during the same 
period, it emphasizes the importance of environmental surveillance work for forecast of high 
risk zones of NoV outbreaks. 
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Introduction 
Blue mussels (Mytilus spp) are filter-feeders and are widespread in European coastal waters, 
which are often in close proximity to urban sewage treatment units.1, 2 Filter-feeders may 
retain particles at 4 μm with 100% efficiency.3 Faecal contamination of water (via sewage 
discharge) poses a serious threat to human health as bivalves (mussels and oysters) which 
filter large volumes of water through their gills as part of their feeding activities, bio-
accumulate pathogenic microbes, including enteric bacteria and viruses. In situ studies with 
bio-accumulation of a virus indicator in oysters have shown that they can effectively 
concentrate viruses (up to 99-fold) compared to the surrounding water.4 An adult blue mussel 
may filter ~ 72 litres of water on an average per day5 and have been proposed as bio-samplers 
for assessment of faecal contamination in recreational waters.6 Consumption of bivalves as 
food is often reported to be the cause of disease outbreaks by enteric viruses. Though primary 
infection results from ingestion of faecal contaminated food or water, unintentional ingestion 
of contaminated recreational waters can also lead to gastrointestinal illness.7 Norovirus 
outbreaks have a distinct seasonality linked to winter months.8, 9  NoV infections are called 
“gastric flu” for its similar seasonality & lack of effective therapeutics like influenza viruses, 
and also for its high infectivity and rapid evolution.10, 11 
Noroviruses (NoVs) are a non-enveloped positive sense single-stranded RNA virus of the 
Caliciviridae family. NoVs have a significant impact on human health as they are highly 
infectious and cause acute gastroenteritis in all age groups accounting for >200,000 deaths 
worldwide each year, especially in children.12 The organism is highly contagious and 
problematic as a hospital-acquired infection. According to WHO, <10 virions are sufficient to 
cause infection in adults and NoV outbreaks often lead to closure of entire hospital wards 
every year affecting both patients and staff. Despite attempts to control via ‘deep cleaning’ 
and implementing hygiene measures outbreaks can cause considerable inconvenience and 
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economic losses.13-15 NoVs cannot be cultured on cells and detection and diagnosis 
increasingly relies solely on molecular methods such as reverse transcriptase-PCR (RT-
PCR).16 Diversity of NoVs both genetically and antigenically were demonstrated through RT-
PCR and genomic sequencing.17 NoVs are divided into six genogroups (GI-GVI) and 
genogroups are further subdivided into around forty genetic clusters or genotypes.18 NoV 
genogroups which infect humans are I (NoV GI), II (NoV GII) and rarely IV (NoV GIV).  
NoV GII.4 is responsible for 80% of the disease outbreaks19 and is currently the most virulent 
strain circulating in the UK.20 Since it has a faster mutation rate than other NoVs21 new 
variants emerge every 2-3 years and is also responsible for 60–80% of outbreaks 
worldwide.22 The GII.4 variant named Sydney 2012 has progressively replaced the 
predecessor GII.4 New Orleans 2009 variant globally.23, 24  
GII.4 outbreaks occurred preferentially during winter months25 and most works have been 
conducted with samples collected during winter months.26 Thus the aim of the present study 
was to screen for NoV contamination/retention in bivalves during the summer months in the 
UK coastal seawaters.  This work contributes to the development of a working methodology 
for the routine surveillance of mussels round the year for identification and genetic 
characterization of enteric pathogenic viruses accumulated within them.  
Materials and Methods 
Collection and Processing of Samples 
Eight wild blue mussels (numbered 1-8) were collected in April 2013; they were attached to a 
nylon rope fragment on the metal supporting girders under Mumbles Pier at The Mumbles, 
Swansea, UK. Another four mussels (numbered 9-12) were obtained in June, 2013 from the 
Royal Dock at Grimsby, UK. Hepatopancreas, gills and gastrointestinal tissues were 
dissected out from these mussels. Tissues (~3.0 g) from mussels 1-4, 5-8 and 9-12 constituted 
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the three pooled samples 1, 2 and 3 respectively. Mussel tissues were triturated; digested with 
proteinase K and centrifuged at 3000g to collect ~5 ml supernatant.27 The supernatant was 
filtered to remove tissue and other debris including unwanted microbes (like bacteria and 
fungi) using 0.45 µM filter (Anachem-Supatop, UK) for further downstream applications. 
Viral RNA Extraction, Reverse Transcription and Nested PCR 
Following processing of the samples, viral RNA was extracted using QIAamp Viral RNA 
Mini kit (Qiagen, Germany) according to the instructions of the manufacturer. Extracted 
RNA (in 60µl water) was used for reverse transcription to cDNA using BioScript RT-PCR 
Kit (Bioline, UK) and NoV-specific reverse primer, 1422.28   
The cDNA was amplified using NoV GI-specific (PCR nos. 443, 446) and GII-specific (PCR 
nos. 443, 444) semi-nested PCRs (Expand High Fidelity PCR kit, Roche, Germany) 
according to previously published protocols.29 These PCRs target part of the NoV RNA 
polymerase, RdRP gene. The PCR numbering has been adopted from the numbering of the 
PCR protocols as previously published. 28 
The target amplicon sizes were 327 bp for the first round PCR (no. 443) for both NoV GI and 
GII; 188 bp for the second round PCR in case of NoV GI and 237 bp for NoVGII. Positive 
PCR-amplified products (electrophoresed on 1.5% agarose gel) were purified and custom-
sequenced for both strands.  
The sequencing primers were the same forward and reverse primers of the respective PCRs 
that resulted in visible bands on the gel (e.g. primers for PCR no. 446 for GI NoV or 444 for 
GII NoV).  
Armoured RNA (Cells-to-cDNA™ II Kit, Ambion, UK) was used as positive control by 
spiking extracted RNA from mussels with the armoured RNA to test for RT and PCR 
inhibitors in the mussel RNA concentrate.  
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Samples 1-3 were further screened for NoV GI and NoV GII capsid genes using nested PCRs 
(PCR nos. 475, 476) and (PCR nos. 437, 438) respectively and also for HAV (PCR nos. 675, 
676) following previously published protocols.28
All three samples were also screened for NoV GIV (PCR nos. 603, 612; 546, 542) and 
COG4F, G4SKR and G4SKF.28, 30 For NoV GIV detection by PCR nos. 603 and 612, the 
reverse primer 1565 used for cDNA synthesis had the sequence as described earlier31 and not 
as described in La Rosa et al. 28 The latter sequence appears to be incorrect. Samples 2 and 3 
were further tested for HEV (PCR nos. 711, 712) and astrovirus (PCR nos. 696, 697).  
Sequencing  
Nucleotide (nt) sequences, confirmed by bi-directional sequencing of the PCR products 
(PCRs 446, 444) were subject to NCBI BLAST for determining genetic matches with 
sequences available in the database. They were then aligned using Clustal W with other 
closely related NoV sequences identified from the BLAST search. A phylogenetic tree was 
generated by the neighbour-joining method using MEGA 632 on 169 nt of RdRP gene 
(pertaining to nt positions 4326-4494 as in JX459908 NoV GII.4 Sydney variant) to 
characterize the NoV strains and study their genetic distances with other closely related NoV 
strains.  
Results  
Sequencing of NoVs 
All three samples were positive for NoV GII-specific PCR (no. 444) (Fig. 1a, b). Samples 2 
and 3 were also positive for NoV GI-specific PCR (no. 446) (Fig.1b, sample 2 is shown) and 
produced PCR products of expected band length (188 bp). All samples were negative for GIV 
NoV. Samples screened for other enteric viruses were also negative (within the limits of 
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bp) observed for HEV in case of sample 3. However, sequencing pooled product from three 
such bands resulted in non-HEV sequences as also in case of non-NoV sequences observed 
for the 188 bp band from the NoV GI-specific PCR (data not shown). GI & GII NoV PCRs 
targeting NoV capsid genes (PCR nos. 476, 438) were negative. 
Relationships with other NoVs 
Phylogenetic analysis of aligned sequences revealed that samples 1 and 2 from Swansea 
clustered closely with several pandemic NoV GII.4 2012 variants. Both samples, however, 
had differences at nucleotide (nt) sequence levels. NoV from sample 1 was named GII. 4 UK 
2013a and that from sample 2 was named GII.4 UK 2013b. The GII.4 Sydney variants of 
NoVs from mussels in the present study clustered with NoVs of Chinese and Taiwanese 
origin (Fig. 1). 
The sample 3 from Grimsby clustered closely with other NoV GII.2 strains and this NoV was 
named GII.2 UK 2013 (Fig. 2). NoV GI-specific PCR products from samples 2 and 3 
produced non-NoV sequences which could not be matched with any known sequence using 
BLAST.  
Though both samples contained NoV GII.4, the predominant strains as preferentially 
amplified by PCRs were different as evident from nucleotide differences in their RdRP gene 
sequences and reflected in phylogenetic clustering (Fig. 2). In the tree, prototype sequence 
from a NoV GII obtained from GenBank (accession number X86557) and an outgroup 
sequence from a NoV GI (GQ845370) were included. Prototype for NoV GII.4 included in 
the tree was the Sydney 2012 variant (accession number JX459907) which interestingly 
caused high incidence of NoV outbreaks in the UK during 2012. Both the NoV GII.4 variants 
from Swansea grouped closely with the 2012 NoV GII.4 human strains, including the 
7“Sydney 2012” variants as detected earlier.24  The most interesting finding of this study is the 
fact that NovGII.4 Sydney variants were found even in a pilot scale of samples which 
advocates for the high prevalence of these pathogenic genotypes in the mussels of UK coastal 
waters.
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Fig. 1: Representative gel electrophoresis gels, for NoV GI (PCR 446) and NoV GII 
(PCR444) from mussel samples 1 and 2. 
a) Mussel sample 1 PCR Lane 1: Hyperladder IV (Bioline, UK); Lane 3: Negative control
for NoV GII-specific PCR (PCR nos. 443, 444; nuclease-free water as template for both 
PCRs); Product for PCR no. 444 was run on gel, Lane 5: NoV GII PCR product (237bp); 
Lane 7: Positive control for PCR inhibitors in mussels (147bp). 
b) Mussel sample 2 PCR Lane 1: Hyperladder IV; Lane 2: NoV GI PCR product (188bp);
Lane 3: NoV GII PCR product (237bp). 
8Figure. 2.  FR669099 NoV GII Luxem 2009 
 FR669098 NoV GII Luxem 2009 
 HM635123 Hu GII 2 Korea 2009 
 Sample 3-Mussels 9-12 (GII.2 UK 2013) 
 EU085490 Hu GII 2 Sweden 2004 Mussels 
 X81879 GII 2-Msham-GBR95 
 GQ845370.2 Hu GII 12 StGeorge 2008 AU 
 JX459907 Hu GII 4 Sydney 2012 
 Sample 1-Mussels 1-4 (GII.4 UK 2013a) 
 Sample 2-Mussels 5-8 (GII.4 UK 2013b) 
 KC688702 NV carrot salad 2012 Germany 
 KC517362 Hu GII 4 2012 TW 
 KF055286 Hu GII 4 Huzhou 2012 CHN 
 KC709613 Hu GII 4 PKUPH 63 2012 CHN 
 KC119508 Hu GII 4 2012 Spain 
 JQ613573 Hu GII 4 2010 AUS 
 X86557 Hu GII 4-Lsdale-GBR-2005 
 X76716 NoV II 4 UK 1994 
 AF093797 NoV I 6 Germany 1997 
Fig. 2: Phylogenetic analysis of the norovirus RNA-dependent RNA polymerase gene (partial) of several NoV genogroups 
and genotypes. NV sequences, retrieved from Genbank for comparing with our NoV strains in the mussels are identified by 
their Genbank accession numbers on the figure. The scale bar indicates genetic distance in terms of nucleotide substitution/
site/year. 
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NoVs are most common cause of outbreaks of food-borne illnesses and pose serious health 
risks to humans. In the present small-scale study, mussel samples obtained from seawater 
near Swansea were found to contain two GII.4 variants. In February 2012, four wards were 
closed in a nearby public hospital due to NoV outbreak (http://www.bbc.com/news/uk-wales-
south-west-wales-17110220 accessed on 14.10.2015). However, if the GII.4 virus strains 
identified in the mussels were genetically identical to the NoV strains responsible for the 
Swansea outbreaks, it would demonstrate that these viruses probably survive the sewage 
treatment process and concentrate in mussels. This could not be analysed in the present study 
as no sequence data on the outbreak of NoV strains from Swansea in 2012 were available in 
the public domain.  In this context, it is worth mentioning that the most commonly detected 
GII.4 strain in the healthcare settings in UK in the season (2013-2015) was Sydney 2012 
(PHE Monthly National Norovirus and Rotavirus Report, 14 April, 2016.33  NoV capsid 
PCRs were negative which could have resulted from primer mismatch as capsid proteins are 
exposed to higher level of immune pressure and therefore, immune selection compared to 
more conserved non-structural proteins like virus RNA-dependent RNA polymerase. 
Consequently, the capsid genes are more prone to higher rates of mutation. As humans are 
mostly infected by the GII strains, the present work indicates the need for a larger study of 
surveillance of enteric viruses (e.g. NoV, HAV virus and HEV, rotaviruses and others) that 
contaminate coastal waters of the UK and become bio-accumulated in mussels, clams and 
oysters34 confirming their role as a food chain source of infection.  
NoV GI and GII have been detected in oyster samples harvested from bays and estuaries 
worldwide 35, 36 and also from human samples.25 However, this is the first report, to the best 
of our knowledge, on NoV GII.4 Sydney 2012 variant detected in blue mussels collected 
from UK coastal waters. It suggests that choosing noroviruses as a parameter would be 
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worthy enough if viral testing of mussels is introduced on a routine basis. It was also 
interesting to note that norovirus is highly detectable even in a small scale sampling of 
mussels during summer months, suggesting the possible prevalence of pathogenic NoV 
strains contaminating UK coastal waters throughout the year.  
It had been reported earlier that NoV outbreaks are more likely to occur during winter4 as 
cold water temperatures and reduced ultraviolet light increase their survival.37 The present 
work detected NoVs to a great extent even in summer months, so it may be proposed that 
mussels act as reservoirs to retain and shelter the viruses round the year so that they can 
contribute to the flux of viable NoVs contamination of sea waters during winter and 
potentiate greater spread to cause severe outbreaks of NoV infections during the winter 
months.   
One limitation of the present work was that the sample size was not large but still comparable 
to that reported earlier.28 Despite pilot level sample size, the interesting and important 
observation was that different pathogenic NOV GII, including GII.4 Sydney variants (as 
evident from sequence variations in the RdRp gene) could be detected from potentially all the 
blue mussels collected. This suggests substantial environmental contamination which perhaps 
explains why Sydney 2012 variant was isolated from most UK outbreaks during 2013-14. 
One possible explanation for the clustering of the GII.4 Sydney variants of NoVs from 
mussels with NoVs of Chinese and Taiwanese origin could be that the mussel collection sites 
in the present study were places where year-round maritime activities take place and coastal 
water contamination from ships and vessels from faraway places could not be ruled out. 
Surveillance and control of NoV outbreaks related to mussel and other shellfish consumption 
is therefore crucial to prevent spread of infection in the population. We believe that this work 
will be an important addendum to the ongoing research in NoV epidemiology in the UK.38-40 
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